Options Brief: Aastrom Biosciences, Inc.

Shares of Aastrom Biosciences, Inc. ASTM are lower on the session by 1.32%, trading at $2.98. Overall call volume is now running at 3.96x the daily average, with 0% of all calls traded being purchases on the offer. 2,400 contracts have traded on the session so far. Aastrom Biosciences, Inc. is in the development-stage. Aastrom is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues.